CYP17A1 and breast cancer: Many studies about the genetic mutations or SNP occurring in CYP17 gene could enhance CYP17’s transcription rate and increase the enzyme cytochrome P450c17 level, resuling in an increasing number of bioavailable estrogen, which is likely to affect the risk and aggressiveness of BC [8].